VIST vs BMA

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 09, 2026

VIST

28.1
AI Score
VS
BMA Wins

BMA

50.8
AI Score

Investment Advisor Scores

VIST

28score
Recommendation
SELL

BMA

51score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric VIST BMA Winner

Relative Price Performance (Last 90 Days)

VIST 1M: +15.5% · 3M: +4.5% BMA 1M: -2.5% · 3M: -20.5%

Current Technical Phase

VIST

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (1.8% over 20 days), RSI 59

RSI (14): 58.7 · Price: $76.27

BMA

Markdown
Sell / avoid

Price below a falling SMA50 (slope -6.6%), weak momentum, RSI 43

RSI (14): 43.1 · Price: $77.82

Fundamentals Snapshot

Metric VIST BMA
Market Cap
Forward P/E 0.5 0.0
Trailing P/E 9.8 20.0
Revenue (TTM)
Revenue Growth 1.0% 0.2%
Gross Margin 0.8% 1.0%
Operating Margin 0.4% 0.3%
EPS 8.05 3.94
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, BMA is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.